Your browser doesn't support javascript.
loading
Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
Hu, Yang; Nie, Hao; Yu, Hai-Han; Qin, Chuan; Wu, Long-Jun; Tang, Zhou-Ping; Tian, Dai-Shi.
Afiliação
  • Hu Y; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Nie H; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Yu HH; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Qin C; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Wu LJ; Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States.
  • Tang ZP; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: ddjtzp@163.com.
  • Tian DS; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: tiands@tjh.tjmu.edu.cn.
Autoimmun Rev ; 18(5): 542-548, 2019 May.
Article em En | MEDLINE | ID: mdl-30844555

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Rituximab Tipo de estudo: Systematic_reviews Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Rituximab Tipo de estudo: Systematic_reviews Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article